The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning
Open accessAbstract
Fungal infection has become one of the leading causes of hospital-acquired infections with high mortality rates. Furthermore, drug resistance is common for fungus-causing diseases. Synergistic drug combinations could provide an effective strategy to overcome drug resistance. Meanwhile, synergistic drug combinations can increase treatment efficacy and decrease drug dosage to avoid toxicity. Therefore, computational prediction of synergistic drug combinations for fungus-causing diseases becomes attractive. In this study, we proposed similar nature of drug combinations: principal drugs which obtain synergistic effect with similar adjuvant drugs are often similar and vice versa. Furthermore, we developed a novel algorithm termed Network-based Laplacian regularized Least Square Synergistic drug combination prediction (NLLSS) to predict potential synergistic drug combinations by integrating different kinds of information such as known synergistic drug combinations, drug-target interactions, and drug chemical structures. We applied NLLSS to predict antifungal synergistic drug combinations and showed that it achieved excellent performance both in terms of cross validation and independent prediction. Finally, we performed biological experiments for fungal pathogen Candida albicans to confirm 7 out of 13 predicted antifungal synergistic drug combinations. NLLSS provides an efficient strategy to identify potential synergistic antifungal combinations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
(2006) · Cited by 3,624
From genomics to chemical genomics: new developments in KEGG
Kanehisa, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj102 · Cited by 3,120
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
Berenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
Calcineurin: Form and Function
Rusnak, F., & Mertz, P. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1483 · Cited by 1,373
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
(1953) · PubMed · Cited by 942
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Vermes, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.171 · Cited by 803
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698
Drug–target interaction prediction: databases, web servers and computational models
Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv066 · Cited by 658
Self-citationSystematic discovery of multicomponent therapeutics
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337088100 · Cited by 620
Analysis of combined drug effects: a new look at a very old problem
Chou, T.-C., & Talalay, P. (1983) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(83)90490-x · Cited by 619
Novel human lncRNA–disease association inference based on lncRNA expression profiles
Chen, X., & Yan, G.-Y. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt426 · Cited by 613
Self-citationSystems biology and combination therapy in the quest for clinical efficacy
Fitzgerald, J. B., Schoeberl, B., Nielsen, U. B., & Sorger, P. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio817 · Cited by 570
Structure of FK506, a novel immunosuppressant isolated from Streptomyces
Tanaka, H., Kuroda, A., Marusawa, H., Hatanaka, H., Kino, T., Goto, T., Hashimoto, M., & Taga, T. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00250a050 · Cited by 512
Amphotericin B: current understanding of mechanisms of action
Brajtburg, J., Powderly, W. G., Kobayashi, G. S., & Medoff, G. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.183 · Cited by 504
Hattori, M., Okuno, Y., Goto, S., & Kanehisa, M. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036030u · Cited by 484
Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces
Xia, Z., Wu, L.-Y., Zhou, X., & Wong, S. T. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-s2-s6 · Cited by 389
Li, S., Zhang, B., & Zhang, N. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s1-s10 · Cited by 380
Semi-supervised learning for potential human microRNA-disease associations inference
Chen, X., & Yan, G.-Y. (2014) · Scientific Reports · doi:10.1038/srep05501 · Cited by 374
Self-citationDiscovery, biochemistry and biology of lovastatin
Alberts, A. W. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90002-1 · Cited by 358
Sanglard, D., Ischer, F., Marchetti, O., Entenza, J., & Bille, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03495.x · Cited by 350
Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands
Chou, T.-C. (1976) · Journal of Theoretical Biology · doi:10.1016/0022-5193(76)90169-7 · Cited by 349
Calcineurin is essential for survival during membrane stress in Candida albicans
Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H., & Heitman, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.546 · Cited by 342
The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
Cowen, L. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1835 · Cited by 311
Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285
Chemical combination effects predict connectivity in biological systems
Lehár, J., Zimmermann, G. R., Krueger, A. S., Molnar, R. A., Ledell, J. T., Heilbut, A. M., Short, G. F., Giusti, L. C., Nolan, G. P., Magid, O. A., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100116 · Cited by 275
Micafungin: A New Echinocandin
Chandrasekar, P. H., & Sobel, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/501020 · Cited by 256
Zhang, L., Yan, K., Zhang, Y., Huang, R., Bian, J., Zheng, C., Sun, H., Chen, Z., Sun, N., An, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609370104 · Cited by 248
Self-citationEffect of combinations : mathematical basis of problem
Loewe, S. (1926) · Medical Entomology and Zoology · Cited by 237
Greco, W. R., Park, H. S., & Rustum, Y. M. (1990) · PubMed · Cited by 219
Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data
Zhao, X.-M., Iskar, M., Zeller, G., Kuhn, M., van Noort, V., & Bork, P. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002323 · Cited by 201
Calcineurin Is Essential for Candida albicans Survival in Serum and Virulence
Blankenship, J. R., Wormley, F. L., Boyce, M. K., Schell, W. A., Filler, S. G., Perfect, J. R., & Heitman, J. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.3.422-430.2003 · Cited by 186
DrugComboRanker: drug combination discovery based on target network analysis
Huang, L., Li, F., Sheng, J., Xia, X., Ma, J., Zhan, M., & Wong, S. T. C. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu278 · Cited by 178
The Effect of Ketoconazole on Amphotericin B in a Model of Disseminated Aspergillosis
Schaffner, A., & Frick, P. G. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.5.902 · Cited by 175
Kelly, R. J., Draper, D., Chen, C. C., Robey, R. W., Figg, W. D., Piekarz, R. L., Chen, X., Gardner, E. R., Balis, F. M., Venkatesan, A. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1725 · Cited by 172
Self-citationHolmes, A. R., Lin, Y.-H., Niimi, K., Lamping, E., Keniya, M., Niimi, M., Tanabe, K., Monk, B. C., & Cannon, R. D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00463-08 · Cited by 159
Caspofungin: A Review of its Use in the Treatment of Fungal Infections
McCormack, P. L., & Perry, C. M. (2005) · Drugs · doi:10.2165/00003495-200565140-00009 · Cited by 145
Synergistic and Antagonistic Drug Combinations Depend on Network Topology
Yin, N., Ma, W., Pei, J., Ouyang, Q., Tang, C., & Lai, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093960 · Cited by 139
Posaconazole: An extended-spectrum triazole antifungal agent
SCHILLER, D., & Fung, H. B. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.015 · Cited by 136
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species
Ryder, N. S., & Leitner, I. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.91.95 · Cited by 129
Ryder, N. S., Wagner, S., & Leitner, I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1057 · Cited by 122
Calcineurin Is Essential for Virulence in Candida albicans
Bader, T., Bodendorfer, B., Schröppel, K., & Morschhäuser, J. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.5344-5354.2003 · Cited by 121
Calcineurin Is Required forCandida albicansTo Survive Calcium Stress in Serum
Blankenship, J. R., & Heitman, J. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.5767-5774.2005 · Cited by 115
ASDCD: Antifungal Synergistic Drug Combination Database
Chen, X., Ren, B., Chen, M., Liu, M.-X., Ren, W., Wang, Q., Zhang, L., & Yan, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086499 · Cited by 103
Self-citationChin, N. X., Weitzman, I., & Della-Latta, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.850 · Cited by 101
High‐order combination effects and biological robustness
Lehár, J., Krueger, A., Zimmermann, G. R., & Borisy, A. A. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.51 · Cited by 101
Lewis, R. E., Lund, B. C., Klepser, M. E., Ernst, E. J., & Pfaller, M. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1382 · Cited by 100
Rodríguez, M. M., Serena, C., Mariné, M., Pastor, F. J., & Guarro, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00628-08 · Cited by 97
Antifungal chemotherapy: advances and perspectives
Groll, A. H., & Walsh, T. J. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.09729 · Cited by 96
Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93
Lewis, R. E., Prince, R. A., Chi, J., & Kontoyiannis, D. P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3208-3214.2002 · Cited by 86
Chemogenomic profiling predicts antifungal synergies
Jansen, G., Lee, A. Y., Epp, E., Fredette, A., Surprenant, J., Harcus, D., Scott, M. S., Tan, E., Nishimura, T., Whiteway, M. S., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.95 · Cited by 84
Amphotericin B and Fluconazole, a Potent Combination Therapy for Cryptococcal Meningitis
Larsen, R. A., Bauer, M., Thomas, A., & Graybill, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.985-991.2004 · Cited by 83
Bagiński, M., Sternal, K., Czub, J., & Borowski, E. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3426 · Cited by 82
Bader, T., Schröppel, K., Bentink, S., Agabian, N., Köhler, G., & Morschhäuser, J. (2006) · Infection and Immunity · doi:10.1128/iai.00142-06 · Cited by 81
Mosquera, J., Sharp, A., Moore, C. B., Warn, P. A., & Denning, D. W. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf111 · Cited by 77
Synergy evaluation by a pathway–pathway interaction network: a new way to predict drug combination
Chen, D., Zhang, H., Lu, P., Liu, X., & Cao, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00599j · Cited by 75
Systematic prediction of drug combinations based on clinical side-effects
Huang, H., Zhang, P., Qu, X. A., Sanseau, P., & Yang, L. (2014) · Scientific Reports · doi:10.1038/srep07160 · Cited by 73
Managing hypertension using combination therapy.
Frank, J. (2008) · PubMed · Cited by 69
Chen, X., Liu, M.-X., Cui, Q., & Yan, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043425 · Cited by 60
Self-citationCantón, E., Pemán, J., Gobernado, M., Viudes, A., & Espinel‐Ingroff, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1593-1596.2005 · Cited by 59
Posaconazole: An Oral Triazole with an Extended Spectrum of Activity
Rachwalski, E. J., Wieczorkiewicz, J. T., & Scheetz, M. H. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l005 · Cited by 56
Disulfiram is a potent modulator of multidrug transporter Cdr1p of Candida albicans
Shukla, S., Sauna, Z. E., Prasad, R., & Ambudkar, S. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.151 · Cited by 53
Martin, E., Maier, F., & Bhakdi, S. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1331 · Cited by 48
Large-Scale Prediction of Beneficial Drug Combinations Using Drug Efficacy and Target Profiles
Iwata, H., Sawada, R., Mizutani, S., Kotera, M., & Yamanishi, Y. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00444 · Cited by 39
Tanabe, K., Lamping, E., Nagi, M., Okawada, A., Holmes, A. R., Miyazaki, Y., Cannon, R. D., Monk, B. C., & Niimi, M. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07820.x · Cited by 24
Statistical Metamodeling for Revealing Synergistic Antimicrobial Interactions
Chen, C. H., Gau, V., Zhang, D. D., Liao, J. C., Wang, F., & Wong, P. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015472 · Cited by 23
Hughes, C. E., Peterson, L. R., Beggs, W. H., & Gerding, D. N. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.1.65 · Cited by 23
Exploring drug combinations in a drug-cocktail network
Xu, K., Hu, F., Song, J., & Zhao, X.-M. (2011) · IEEE International Conference on Systems Biology · doi:10.1109/isb.2011.6033183 · Cited by 8
Fluconazole, caspofungin, voriconazole in combination with amphotericin B
Kalkancı, A., Dizbay, M., Sarı, N., Yalçin, B., Fidan, I., Arman, D., & Kuştımur, S. (2010) · Open Medicine · doi:10.2478/s11536-010-0010-0 · Cited by 5
Chou, T. (1977) · The Pharmacologist · Cited by 5
Cited by
Modeling polypharmacy side effects with graph convolutional networks
Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501
Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675
DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 653
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Zhang, L., Ai, H., Chen, W., Yin, Z., Hu, H., Zhu, J., Zhao, J., Zhao, Q., & Liu, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-02365-0 · Cited by 254
Self-citation
Metadata
- Authors
- Chen, X., Ren, B., Chen, M., Wang, Q., Zhang, L., & Yan, G.
- Venue
- PLOS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-07-14
- Volume
- 12
- Issue
- 7
- Pages
- e1004975
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- OpenAlex
- W2473876819
- Cited by
- 279
- References
- 77
- FWCI
- 30.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.